Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Free light chains in the CSF in multiple sclerosis.

F Bracco, P Gallo, R Menna

    Journal of Neurology
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Leveraging transfer learning for efficient bioprinting.

    Biofabrication·2025
    Same author

    Fatty acid content profile and main constituents of Corylus avellana kernel in wild type and cultivars growing in Italy.

    Natural product research·2016
    Same author

    Gender differences in migraine.

    Acta neuropsychiatrica·2014
    Same author

    The neurobiology of imagination: possible role of interaction-dominant dynamics and default mode network.

    Frontiers in psychology·2013
    Same author

    Aspects on the integrative actions of the brain from neural networks to "brain-body medicine".

    Journal of receptor and signal transduction research·2012
    Same author

    Mild traumatic brain injury.

    European journal of neurology·2012

    Free light chains (FLC) are frequently detected in cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients, indicating active central nervous system inflammation. Their presence, second only to IgG bands, suggests recent immunological activity in MS.

    Area of Science:

    • Neuroimmunology
    • Clinical Chemistry

    Background:

    • Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
    • Intrathecal immunoglobulin synthesis is a hallmark of MS pathogenesis.
    • Free light chains (FLC) are potential biomarkers of B-cell activation and inflammation.

    Purpose of the Study:

    • To investigate the presence and significance of free light chains (FLC) in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS).
    • To compare the diagnostic utility of FLC detection with other established markers of intrathecal immunological activity in MS.

    Main Methods:

    • Agarose isoelectric focusing followed by immunofixation was used to detect kappa and lambda FLC in unconcentrated CSF.
    • CSF samples from 32 MS patients, 2 neurosyphilis patients, and 10 healthy controls were analyzed.

    Related Experiment Videos

  • FLC detection was compared with IgG oligoclonal bands, IgG index, and pleocytosis.

    • Main Results:

    • FLC were detected in the CSF of 28 out of 32 MS patients (87.5%).
    • FLC were observed in both neurosyphilis cases but never in healthy controls.
    • FLC detection was the second most frequent abnormality in MS CSF, after IgG oligoclonal bands.
    • A strong correlation was found between elevated FLC levels and pleocytosis in MS patients.

    Conclusions:

    • The presence of FLC in MS CSF is a frequent finding, suggesting active B-cell stimulation and immunoglobulin production within the central nervous system.
    • FLC represent a valuable biomarker for recent immunological activity in MS.
    • FLC detection can aid in the diagnosis and monitoring of inflammatory neurological conditions like MS.